Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
DLEC1 contains 37 exons, spans approximately 59-kb, and is located in the 3p22-p21.3 chromosomal segment that is commonly deleted in various carcinomas. Additionally we are shipping and and many more products for this protein.
Showing 10 out of 52 products:
We found no correlation between the DLEC1, TUSC4 (show NPRL2 Antibodies) and MLH1 (show MLH1 Antibodies) gene expression and NSCLC patient characteristics (gender, age and smoking) or cancer histopathology. No significant differences in the gene expression among NSCLC subtypes indicate the weakness of DLEC1, TUSC4 (show NPRL2 Antibodies) and MLH1 (show MLH1 Antibodies) expression analysis as potential differentiating markers of NSCLC subtypes in the Polish population.
the expression levels of DLEC1 and ITGA9 were prominently decreased in lung tumor samples
DLEC1 mediates tumor-suppressive activities through NF-kappaB (show NFKB1 Antibodies) signaling.
DLEC1 methylation was not associated with the clinicopathological variables of gastric cancer.
DLEC1 is down-regulated in head and neck squamous cell tumors and it's promoter methylation is not associated with the clinicopathological parameters.
methylation-mediated silencing of DLEC1 plays an important role in multiple lymphomagenesis, and may serve as a non-invasive tumor marker for lymphoma diagnosis
Repression of DLEC1 in squamous cell carcinoma tissues is associated with promoter hypermethylation. DLEC1 is downregulated in sinonasal squamous cell carcinoma and inverted papilloma and has a distinct mechanism.
Epigenetic inactivation of DLEC1 was crucial in gastric and colorectal carcinogenesis. DLEC1 methylation in serum may be a promise biomarker for GAC (show GLS Antibodies) and CRAC early diagnosis.
results demonstrate that down-expression and promoter methylation of DLEC1 increased from normal tissues to premalignancies and then to malignancies.
Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation is associated with non-small-cell lung cancer.
This gene contains 37 exons, spans approximately 59-kb, and is located in the 3p22-p21.3 chromosomal segment that is commonly deleted in various carcinomas. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins. Aberrant transcription of this gene may be involved in carcinogenesis of the lung, esophagus, and kidney.
deleted in lung and esophageal cancer 1
, deleted in lung and esophageal cancer protein 1-like
, deleted in lung and esophageal cancer 1 transcript varient 2
, deleted in lung and esophageal cancer protein 1
, deleted in lung and esophageal cancer protein 1 homolog
, deleted in lung and esophageal cancer 1 isoform DLEC1-N1